| CAT No: | CL-TMDS-20 |
| CAS No: | NA |
| Mol.F: | C21H22Cl2N2O7 |
| Mol.Wt.: | 485.3 |
| Rel. Cas No: | |
| Chemical Name: | 2-(3,5-Dichlorophenyl)-N-methyl-N-((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)benzo[d]oxazole-6-carboxamide |
| SMILES: | CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=O)c1ccc2nc(oc2c1)c3cc(Cl)cc(Cl)c3 |
| Inventory Status: | Custom synthesis |
This impurity is related to Tafamidis Impurity 19 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Tafamidis Impurity 19 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-(3,5-Dichlorophenyl)-N-methyl-N-((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)benzo[d]oxazole-6-carboxamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Tafamidis Molecular Formula: C21H22Cl2N2O7
Molecular Weight: 485.3
Storage: Store in a cool, dry place.
| Product Name: | Tafamidis Impurity 19 |
| CAS No: | NA |
| Mol.F.: | C21H22Cl2N2O7 |
| Mol.Wt.: | 485.3 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: